1.61
Finanzdaten der Pliant Therapeutics Inc-Aktie (PLRX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
|
|
22.64%
45.59
|
58.94 | 62.01 | 60.64 | 52.39 |
| Operating Income/Loss |
22.64%
-45.59
|
-58.94 | -62.01 | -60.64 | -52.39 |
| Income/Loss From Continuing Operations Before Tax |
22.91%
-43.30
|
-56.17 | -57.76 | -55.85 | -46.95 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
22.91%
-43.30
|
-56.17 | -57.76 | -55.85 | -46.95 |
|
|
22.91%
-43.30
|
-56.17 | -57.76 | -55.85 | -46.95 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.27%
61.39
|
61.22 | 60.73 | 60.38 | 60.18 |
| Diluted Average Shares |
0.27%
61.39
|
61.22 | 60.73 | 60.38 | 60.18 |
| Basic Earnings Per Share |
22.83%
-0.71
|
-0.92 | -0.95 | -0.92 | -0.78 |
| Diluted Earnings Per Share |
22.83%
-0.71
|
-0.92 | -0.95 | -0.92 | -0.78 |
| Common Stock Dividends |
-
|
- | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):